M

MDxHealth SA
NASDAQ:MDXH

Watchlist Manager
MDxHealth SA
NASDAQ:MDXH
Watchlist
Price: 1.94 USD 3.74% Market Closed
Market Cap: 96m USD
Have any thoughts about
MDxHealth SA?
Write Note

Relative Value

The Relative Value of one MDXH stock under the Base Case scenario is 9.14 USD. Compared to the current market price of 1.94 USD, MDxHealth SA is Undervalued by 79%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MDXH Relative Value
Base Case
9.14 USD
Undervaluation 79%
Relative Value
Price
M
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
89
Median 3Y
2.5
Median 5Y
23.2
Industry
7.7
Forward
1.1
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-8.8
Industry
22.7
Forward
-1.6
vs History
vs Industry
22
Median 3Y
7.7
Median 5Y
11.6
Industry
2.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
N/A

Multiples Across Competitors

MDXH Competitors Multiples
MDxHealth SA Competitors

All Multiples
P/S
P/E
P/B
All Countries
Close
Market Cap P/S P/E P/B
BE
MDxHealth SA
NASDAQ:MDXH
96m USD 0.8 -1.6 -10.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 797 580.3 -179 646.3 -184 799.1
US
Abbvie Inc
NYSE:ABBV
320.1B USD 5.8 63 53.1
US
Amgen Inc
NASDAQ:AMGN
150.5B USD 4.6 35.6 20
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.4B USD 11.3 -250.9 7.7
US
Gilead Sciences Inc
NASDAQ:GILD
113.8B USD 4 903.4 6.2
US
Epizyme Inc
F:EPE
94.1B EUR 1 863.9 -475.6 -4 871.5
AU
CSL Ltd
ASX:CSL
135.4B AUD 5.9 33.1 5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.9B USD 6 17.8 2.8
US
Seagen Inc
F:SGT
39.3B EUR 18 -55.1 16.2
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.7 8.5
P/E Multiple
Earnings Growth
BE
M
MDxHealth SA
NASDAQ:MDXH
Average P/E: 210.6
Negative Multiple: -1.6
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -179 646.3 N/A
US
Abbvie Inc
NYSE:ABBV
63
412%
US
Amgen Inc
NASDAQ:AMGN
35.6
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -250.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
903.4
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -475.6 N/A
AU
CSL Ltd
ASX:CSL
33.1
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.1 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.7 N/A

See Also

Discover More
Back to Top